Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0032617 (
polyuria
)
3,056
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A 2-year-old male Labrador Retriever was presented to the University of Missouri Veterinary Teaching Hospital with the primary complaints of polydipsia,
polyuria
, and joint or muscle pain. Low blood urea nitrogen concentration,
hyperchloremia
, and marked proteinuria were the only abnormalities in a serum biochemical profile and urinalysis. Decreased creatinine clearance and increased renal fractional excretion of sodium, potassium, calcium, and phosphorus were detected by renal clearance studies. Increased excretion of most amino acids was found by amino acid analysis of urine, but not all amino acids were lost with equal magnitude. Amino acids with secondary amino groups or basic side chains were lost at increased rates, whereas those with acidic side chains were not. These differences could be related to defects in specific renal amino acid transport mechanisms. Identification of these transport mechanisms may allow for pharmacologic intervention at the point of renal loss to alleviate clinical signs of disease.
...
PMID:Fanconi syndrome in a Labrador retriever. 788 24
A 16-month-old Wagyu heifer calf presented for depression, inappetence, and
polyuria
/polydipsia. Physical examination revealed that the heifer calf was mentally dull, subjectively small for her age, bradycardic, and hypothermic and had bilateral nasal discharge. Laboratory tests revealed marked serum and cerebrospinal fluid hypernatremia and
hyperchloremia
with increased cerebrospinal fluid protein. The heifer calf was treated with Ringer solution intravenously for dehydration and electrolyte abnormalities, and with 1 dose each of thiamine and penicillin. Clinical deterioration prompted the owner to elect humane euthanasia. Necropsy revealed a mass lesion in the suprasellar region. Histopathology was consistent with a suprasellar germ cell tumor; the mass stained positive on immunohistochemistry for cytokeratin, vimentin, and c-kit. Suprasellar germ cell tumors have previously been reported in human beings and dogs.
...
PMID:A suprasellar germ cell tumor in a 16-month-old Wagyu heifer calf. 2252 31
Primary distal renal tubular acidosis (dRTA) is a rare genetic disorder caused by impaired distal acidification due to a failure of type A intercalated cells (A-ICs) in the collecting tubule. dRTA is characterized by persistent
hyperchloremia
, a normal plasma anion gap, and the inability to maximally lower urinary pH in the presence of systemic metabolic acidosis. Common clinical features of dRTA include vomiting, failure to thrive,
polyuria
, hypercalciuria, hypocitraturia, nephrocalcinosis, nephrolithiasis, growth delay, and rickets. Mutations in genes encoding three distinct transport proteins in A-ICs have been identified as causes of dRTA, including the B1/
ATP6V1B1
and a4/
ATP6V0A4
subunits of the vacuolar-type H
+
-ATPase (H
+
-ATPase) and the chloride-bicarbonate exchanger AE1/
SLC4A1
. Homozygous or compound heterozygous mutations in
ATP6V1B1
and
ATP6V0A4
lead to autosomal recessive (AR) dRTA. dRTA caused by
SLC4A1
mutations can occur with either autosomal dominant or AR transmission. Red blood cell abnormalities have been associated with AR dRTA due to
SLC4A1
mutations, including hereditary spherocytosis, Southeast Asia ovalocytosis, and others. Some patients with dRTA exhibit atypical clinical features, including transient and reversible proximal tubular dysfunction and hyperammonemia. Incomplete dRTA presents with inadequate urinary acidification, but without spontaneous metabolic acidosis and recurrent urinary stones. Heterozygous mutations in the AE1 or H
+
-ATPase genes have recently been reported in patients with incomplete dRTA. Early and sufficient doses of alkali treatment are needed for patients with dRTA. Normalized serum bicarbonate, urinary calcium excretion, urinary low-molecular-weight protein levels, and growth rate are good markers of adherence to and/or efficacy of treatment. The prognosis of dRTA is generally good in patients with appropriate treatment. However, recent studies showed an increased frequency of chronic kidney disease (CKD) in patients with dRTA during long-term follow-up. The precise pathogenic mechanisms of CKD in patients with dRTA are unknown.
...
PMID:Improving outcomes for patients with distal renal tubular acidosis: recent advances and challenges ahead. 3058 51
Congenital nephrogenic diabetes insipidus (CNDI) is a rare renal disorder caused by mutations in arginine vasopressin receptor 2 (AVPR2) or aquaporin 2 (AQP2). The clinical signs of CNDI include
polyuria
, compensatory polydipsia, dehydration, electrolyte disorder, and developmental retardation without prompt treatment. In this study we report a rare case of CNDI caused by a single base transition in
AQP2
gene. A 4.5 years old male patient suffered from oral dryness, polydipsia, and
polyuria
for more than 3 years. Laboratory examinations showed hypernatremia,
hyperchloremia
, and decreased urine osmolality and specific gravity. Ultrasound and MRI found bilateral upper ureteral dilatation and hydronephrosis. Furthermore, sequencing analysis found a C>T transition leading to a T108M missense mutation of AQP2. The patient was given low sodium diet and treated with hydrochlorothiazide followed by amiloride with indomethacin. The patient's clinical course improved remarkably after 1 year of treatment. This study reports the first case of CNDI featuring T108M missense mutation alone. These findings demonstrate a causative role of T108M mutation for CNDI and contribute to the mechanistic understanding of CNDI disease process.
...
PMID:A Case of Congenital Nephrogenic Diabetes Insipidus Caused by Thr108Met Variant of Aquaporin 2. 3208 42